Daily Equity Report 24 OCT 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 24THOCT 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! INDIAN EQUITY BENCHMARK- Equity benchmark indices rebound from day’s low and hit fresh intraday high in the NIFTY morning trade, with the Nifty50 heading towards the 11,650 level. The Sensex was up 205 points at 39,169 and the CLOSE PREVIOUS Nifty50 index was up 51 points at 11,640. The market NIKKEI breadth was positive on the NSE, 950 shares rose and 713 shares fell. A total of 464 shares were unchanged. ! 2088.86 GLOBAL FACE SECTORIAL INDICES ! CLOSE CHANGE (%) Asian Market- Asian markets finished mixed as of the most recent closing prices. The Nikkei 225 gained 0.34%, while the 11762.4 0.11 Hang Seng led the Shanghai Composite lower. They fell 0.82% and 0.43% respectively. S&P CNX 500 9458.65 0.11 4460.45 0.07 ! U.S. Market – North and South American markets finished mixed as of the most recent closing prices. The Bovespa 5991.45 0.11 29459.6 0.16 gained 1.28%, while the S&P 500 led the IPC lower. They fell 0.36% and 0.10% respectively. TOP GAINERS ! CLOSE CHANGE (%) European markets- European markets are mixed today. The FTSE 100 is up 0.39% while the DAX gains 0.04%. The CAC 40 HCLTECH 1102.00 3.53 is off 0.39%. 2.51 650.35 2.33 MARUTI 224.35 2.12 TOP LOSERS CLOSE CHANGE (%) ADANIPORTS 395.10 -6.10 BHARTIARTL 360.40 -3.66 ZEEL 242.00 -3.37 145.90 -2.18 Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. NIFTY SPOT MARKET MOVERS UPSIDE STRATEGY CLOSE (%) 1.39 2144.20 PIVOT POINTS P 11603 R1 R2 11700 2082.00 1.49 TCS 11409 11506 11555 11652 11797 SBIN 275.35 1.79 S1-11555 S2-11506 R1-11652 R2-11700 BRITANNIA 3300.00 1.60 MARKET MOVERS DOWNSIDE (%) -1.47 -1.52 51.00 -1.54 ONGC -1.56 NET FII DII 6121.99 NSE TOTALS BULLISH PIVOT POINTS P 29457 R1 29793 R3 30663 NIFTY 28251 28854 29190 30060 6 6 S1-29190 S2-28854 R1-29793 R2-30060 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS ! L&T Hydrocarbon wins megaâ order from HPCL L&T Hydrocarbon Engineering Limited (LTHE), a wholly-owned subsidiary of Larsen & Toubro, has been awarded a mega project by Hindustan Petroleum Corporation Limited (HPCL). The company won mega order of Rs7, 000cr. The engineering, procurement, construction and commissioning (EPCC) contract is for setting up a Residue Upgradation Facility (RUF), EPCC-03 Package for Visakh Refinery Modernisation Project (VRMP) at HPCL's Vizag Refinery. The RUF plant is licensed by Chevron Lummus Global (CLG) with a capacity of 3.55 MMTPA. Bajaj Auto reports 22% yoy rise in net profit ! Bajaj Auto's net profit increased by 22% to Rs1,402cr in Q2FY20 led by a tax expense reversal of Rs182cr due to the recent lowering of the corporate tax rate. However, the companyâs revenue fell by 4% tos7, 707.3cr in the second quarter of the current financial year. Tax expenses also declined to Rs206.49cr in Q2FY20 over Rs500.17cr in Q2FY19. ! Dr. nationwide products in the US Market Reddys confirms of voluntary Ranitidine recall all ! Dr. Reddy's Laboratories confirmed on Wednesday that it had initiated a voluntary nationwide recall on October 1, 2019, (at the retail level for over-the-counter products and at the consumer level for prescription products) of all of its ranitidine medications sold in the US due to confirmed contamination with NNitrosodimethylamine (NDMA) above levels established by the FDA. This recall follows the USFDA's caution note alerting patients and health care professionals that NDMA was found in certain samples of ranitidine. ! Strides Pharma receives zero 483 observations for Alathur facility ! Strides Pharma informed the exchanges on Wednesday that its formulations facility in Alathur, India, was inspected by the USFDA in August 2019. The facility has received the Establishment Inspection Report (EIR), thereby confirming the successful closure of the inspections. The inspection conducted in August 2019 had concluded with Zero 483 observations. Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. NAME OF THE STOCK : NIITTECH DATE : 24/10/2019 SEGMENT : CASH CHART TYPE : Candlestick : NSE : NSE EXCHANGE EXCHANGE TECHNICAL INDICATORS USED : VOLUME.MACD, RSI. CHART INVESTMENT ADVICE: CALL CS CALL: - BUY NIITTECH CASH NR CMP 1468 TGT 1488 SL 1448 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Mcx Tips Financial advisory company Sharemarket company Stock Cash Intraday Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.com Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.